Cite
Wang D, Li S, Gessler DJ, et al. A Rationally Engineered Capsid Variant of AAV9 for Systemic CNS-Directed and Peripheral Tissue-Detargeted Gene Delivery in Neonates. Mol Ther Methods Clin Dev. 2018;9:234-246doi: 10.1016/j.omtm.2018.03.004.
Wang, D., Li, S., Gessler, D. J., Xie, J., Zhong, L., Li, J., Tran, K., Van Vliet, K., Ren, L., Su, Q., He, R., Goetzmann, J. E., Flotte, T. R., Agbandje-McKenna, M., & Gao, G. (2018). A Rationally Engineered Capsid Variant of AAV9 for Systemic CNS-Directed and Peripheral Tissue-Detargeted Gene Delivery in Neonates. Molecular therapy. Methods & clinical development, 9234-246. https://doi.org/10.1016/j.omtm.2018.03.004
Wang, Dan, et al. "A Rationally Engineered Capsid Variant of AAV9 for Systemic CNS-Directed and Peripheral Tissue-Detargeted Gene Delivery in Neonates." Molecular therapy. Methods & clinical development vol. 9 (2018): 234-246. doi: https://doi.org/10.1016/j.omtm.2018.03.004
Wang D, Li S, Gessler DJ, Xie J, Zhong L, Li J, Tran K, Van Vliet K, Ren L, Su Q, He R, Goetzmann JE, Flotte TR, Agbandje-McKenna M, Gao G. A Rationally Engineered Capsid Variant of AAV9 for Systemic CNS-Directed and Peripheral Tissue-Detargeted Gene Delivery in Neonates. Mol Ther Methods Clin Dev. 2018 Mar 16;9:234-246. doi: 10.1016/j.omtm.2018.03.004. eCollection 2018 Jun 15. PMID: 29766031; PMCID: PMC5948233.
Copy
Download .nbib